Middle Meningeal Artery Embolization for the Treatment of Unilateral Large Chronic Subdural Hematoma Patients with Significant Midline Shift: A Single-center Experience

Overview

Journal Interv Neuroradiol

Publisher Sage Publications

Specialty Neurology

Date 2024 Mar 22

PMID 38515352

Authors

Yin Niu

Qiang Zhang

Zhouyang Jiang

Wenyan Li

Zhi Chen

Affiliations

Soon will be listed here.

Abstract

Background: The amount of midline shift (MLS) considered safe for middle meningeal artery embolization (MMAE) in patients with chronic subdural hematoma (CSDH) has not been established. Whether MMAE could be used as upfront treatment for unilateral large CSDH patients with significant MLS (>1 cm) has not been reported.

Objective: To investigate the efficacy and safety of MMAE in unilateral large CSDH patients with MLS > 1 cm.

Methods: Eleven carefully selected CSDH patients with mild or moderate symptoms and significant MLS > 1 cm from 1 May 2021 to 31 August 2022 were included in the study. All patients were treated with MMAE using polyvinyl alcohol (PVA) particles. Outcomes were assessed clinically and with interval imaging studies at follow-up.

Results: All 19 MMAs (unilateral embolization in three patients and bilateral embolization in eight patients) were successfully embolized. All 11 patients were followed for subsequent months, and there was no recurrence and enlargement of CSDH. Procedural adverse events, mortality, or complications were not observed. The average time to achieve a 50% reduction in MLS was approximately four weeks, while it took approximately eight weeks to achieve a 50% reduction in maximal volume. All 11 patients showed improvement in their neurological symptoms at three days post-operation, including four hemiplegic patients.

Conclusions: MMAE may demonstrate safety in carefully selected CSDH patients with significant midline shift (MLS > 1 cm), particularly in those who are not suitable for surgery, thus providing a potential alternative approach.

References

Ishihara H, Ishihara S, Kohyama S, Yamane F, Ogawa M, Sato A . Experience in endovascular treatment of recurrent chronic subdural hematoma. Interv Neuroradiol. 2010; 13 Suppl 1:141-4. PMC: 3345458. DOI: 10.1177/15910199070130S121. View

Slotty P, Kamp M, Steiger S, Cornelius J, Macht S, Stummer W . Cerebral perfusion changes in chronic subdural hematoma. J Neurotrauma. 2012; 30(5):347-51. DOI: 10.1089/neu.2012.2644. View

Gomez-Paz S, Akamatsu Y, Salem M, Enriquez-Marulanda A, Robinson T, Ogilvy C . Upfront middle meningeal artery embolization for treatment of chronic subdural hematomas in patients with or without midline shift. Interv Neuroradiol. 2020; 27(4):571-576. PMC: 8580532. DOI: 10.1177/1591019920982816. View

Hubbard Z, Al Kasab S, Porto G, Spiotta A . Chronic subdural hematoma recurrence due to contralateral neovascularization following middle meningeal artery embolization. Interv Neuroradiol. 2021; 28(6):639-643. PMC: 9706259. DOI: 10.1177/15910199211065197. View

Joyce E, Bounajem M, Scoville J, Thomas A, Ogilvy C, Riina H . Middle meningeal artery embolization treatment of nonacute subdural hematomas in the elderly: a multiinstitutional experience of 151 cases. Neurosurg Focus. 2020; 49(4):E5. DOI: 10.3171/2020.7.FOCUS20518. View

Al-Mufti F, Kaur G, Amuluru K, Cooper J, Dakay K, El-Ghanem M . Middle Meningeal Artery Embolization Using Combined Particle Embolization and -BCA with the Dextrose 5% in Water Push Technique for Chronic Subdural Hematomas: A Prospective Safety and Feasibility Study. AJNR Am J Neuroradiol. 2021; 42(5):916-920. PMC: 8115365. DOI: 10.3174/ajnr.A7077. View

Mandai S, Sakurai M, Matsumoto Y . Middle meningeal artery embolization for refractory chronic subdural hematoma. Case report. J Neurosurg. 2000; 93(4):686-8. DOI: 10.3171/jns.2000.93.4.0686. View

Adusumilli G, Ghozy S, Kallmes K, Hardy N, Tarchand R, Zinn C . Common data elements reported on middle meningeal artery embolization in chronic subdural hematoma: an interactive systematic review of recent trials. J Neurointerv Surg. 2022; 14(10):1027-1032. DOI: 10.1136/neurintsurg-2021-018430. View

Edlmann E, Giorgi-Coll S, Whitfield P, Carpenter K, Hutchinson P . Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation. 2017; 14(1):108. PMC: 5450087. DOI: 10.1186/s12974-017-0881-y. View

10.

Salem M, Kuybu O, Hoang A, Baig A, Khorasanizadeh M, Baker C . Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Predictors of Clinical and Radiographic Failure from 636 Embolizations. Radiology. 2023; 307(4):e222045. PMC: 10323293. DOI: 10.1148/radiol.222045. View

11.

Drake M, Ullberg T, Nittby H, Marklund N, Wasselius J . Swedish trial on embolization of middle meningeal artery versus surgical evacuation in chronic subdural hematoma (SWEMMA)-a national 12-month multi-center randomized controlled superiority trial with parallel group assignment, open treatment.... Trials. 2022; 23(1):926. PMC: 9641832. DOI: 10.1186/s13063-022-06842-4. View

12.

Catapano J, Koester S, Srinivasan V, Rumalla K, Baranoski J, Rutledge C . Total 1-year hospital cost of middle meningeal artery embolization compared to surgery for chronic subdural hematomas: a propensity-adjusted analysis. J Neurointerv Surg. 2021; 14(8):804-806. DOI: 10.1136/neurintsurg-2021-018327. View

13.

Kolias A, Chari A, Santarius T, Hutchinson P . Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol. 2014; 10(10):570-8. DOI: 10.1038/nrneurol.2014.163. View

14.

Tempaku A, Yamauchi S, Ikeda H, Tsubota N, Furukawa H, Maeda D . Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: Five cases and a review of the literature. Interv Neuroradiol. 2015; 21(3):366-71. PMC: 4757256. DOI: 10.1177/1591019915583224. View

15.

Ban S, Hwang G, Byoun H, Kim T, Lee S, Bang J . Middle Meningeal Artery Embolization for Chronic Subdural Hematoma. Radiology. 2017; 286(3):992-999. DOI: 10.1148/radiol.2017170053. View

16.

Kan P, Maragkos G, Srivatsan A, Srinivasan V, Johnson J, Burkhardt J . Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Multi-Center Experience of 154 Consecutive Embolizations. Neurosurgery. 2020; 88(2):268-277. DOI: 10.1093/neuros/nyaa379. View

17.

Matsumoto H, Hanayama H, Okada T, Sakurai Y, Minami H, Masuda A . Clinical investigation of chronic subdural hematoma with impending brain herniation on arrival. Neurosurg Rev. 2017; 41(2):447-455. DOI: 10.1007/s10143-017-0861-9. View

18.

Fiorella D, Arthur A . Middle meningeal artery embolization for the management of chronic subdural hematoma: what a difference a few years make. J Neurointerv Surg. 2023; 15(6):515-516. DOI: 10.1136/jnis-2023-020498. View

19.

Hirai S, Ono J, Odaki M, Serizawa T, Nagano O . Embolization of the Middle Meningeal Artery for Refractory Chronic Subdural Haematoma. Usefulness for Patients under Anticoagulant Therapy. Interv Neuroradiol. 2010; 10 Suppl 2:101-4. PMC: 3522210. DOI: 10.1177/15910199040100S218. View

20.

Takizawa K, Sorimachi T, Ishizaka H, Osada T, Srivatanakul K, Momose H . Enlargement of the middle meningeal artery on MR angiography in chronic subdural hematoma. J Neurosurg. 2015; 124(6):1679-83. DOI: 10.3171/2015.5.JNS1567. View